8-K//Current report
Ultragenyx Pharmaceutical Inc. 8-K
Accession 0001193125-17-287334
$RARECIK 0001515673operating
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 4:18 PM ET
Size
6.2 MB
Accession
0001193125-17-287334
Documents
- 8-Kd458520d8k.htmPrimary
FORM 8-K
- EX-99.1d458520dex991.htm
EX-99.1
- EX-99.2d458520dex992.htm
EX-99.2
- GRAPHICg458520ex99_2s10g1.jpg
GRAPHIC
- GRAPHICg458520ex99_2s11g1.jpg
GRAPHIC
- GRAPHICg458520ex99_2s12g1.jpg
GRAPHIC
- GRAPHICg458520ex99_2s13g1.jpg
GRAPHIC
- GRAPHICg458520ex99_2s14g1.jpg
GRAPHIC
- GRAPHICg458520ex99_2s15g1.jpg
GRAPHIC
- GRAPHICg458520ex99_2s1g1.jpg
GRAPHIC
- GRAPHICg458520ex99_2s2g1.jpg
GRAPHIC
- GRAPHICg458520ex99_2s3g1.jpg
GRAPHIC
- GRAPHICg458520ex99_2s4g1.jpg
GRAPHIC
- GRAPHICg458520ex99_2s5g1.jpg
GRAPHIC
- GRAPHICg458520ex99_2s6g1.jpg
GRAPHIC
- GRAPHICg458520ex99_2s7g1.jpg
GRAPHIC
- GRAPHICg458520ex99_2s8g1.jpg
GRAPHIC
- GRAPHICg458520ex99_2s9g1.jpg
GRAPHIC
- GRAPHICg458520g0918143805881.jpg
GRAPHIC
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001515673
Filing Metadata
- Form type
- 8-K
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 4:18 PM ET
- Size
- 6.2 MB